The Enhanced Recovery After Surgery (ERAS) protocol in head and neck cancer : a matched-pair analysis
Copyright © 2022 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy..
Objective: In this study, we aimed to describe the prospective implementation of the Enhanced Recovery after Surgery (ERAS) protocol in an Italian tertiary academic centre.
Methods: Adult patients receiving surgery for primary or recurrent clinical stage III/IV squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx were enrolled. The primary objective was to evaluate the impact of the ERAS protocol on length of hospital stay (LOS). The secondary objective was to assess its impact on complications. To evaluate the results of the ERAS protocol, a matched-pair analysis was conducted, comparing ERAS patients with comparable cases treated before 2018.
Results: Forty ERAS and 40 non-ERAS patients were analysed. There were no significant differences between the cohorts regarding age, gender, stage of disease, comorbidity, ASA score, and duration of surgery. A significantly shorter LOS for the ERAS group (median, 14 days; range, 10-19) than for non-ERAS patients (median, 17.5 days; range, 13-21) was observed (p = 0.0128). The incidence of complications was not significantly different (p = 0.140).
Conclusions: Our study demonstrates that the introduction of an ERAS protocol in the daily practice is feasible, and can result in significant reduction in LOS.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale - 42(2022), 4 vom: 01. Aug., Seite 325-333 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bertazzoni, Giacomo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Enhanced recovery after surgery |
|---|
| Anmerkungen: |
Date Completed 19.10.2022 Date Revised 25.10.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.14639/0392-100X-N2072 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347695264 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347695264 | ||
| 003 | DE-627 | ||
| 005 | 20231226034436.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.14639/0392-100X-N2072 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1158.xml |
| 035 | |a (DE-627)NLM347695264 | ||
| 035 | |a (NLM)36254650 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bertazzoni, Giacomo |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Enhanced Recovery After Surgery (ERAS) protocol in head and neck cancer |b a matched-pair analysis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.10.2022 | ||
| 500 | |a Date Revised 25.10.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy. | ||
| 520 | |a Objective: In this study, we aimed to describe the prospective implementation of the Enhanced Recovery after Surgery (ERAS) protocol in an Italian tertiary academic centre | ||
| 520 | |a Methods: Adult patients receiving surgery for primary or recurrent clinical stage III/IV squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx were enrolled. The primary objective was to evaluate the impact of the ERAS protocol on length of hospital stay (LOS). The secondary objective was to assess its impact on complications. To evaluate the results of the ERAS protocol, a matched-pair analysis was conducted, comparing ERAS patients with comparable cases treated before 2018 | ||
| 520 | |a Results: Forty ERAS and 40 non-ERAS patients were analysed. There were no significant differences between the cohorts regarding age, gender, stage of disease, comorbidity, ASA score, and duration of surgery. A significantly shorter LOS for the ERAS group (median, 14 days; range, 10-19) than for non-ERAS patients (median, 17.5 days; range, 13-21) was observed (p = 0.0128). The incidence of complications was not significantly different (p = 0.140) | ||
| 520 | |a Conclusions: Our study demonstrates that the introduction of an ERAS protocol in the daily practice is feasible, and can result in significant reduction in LOS | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a enhanced recovery after surgery | |
| 650 | 4 | |a head and neck cancer | |
| 650 | 4 | |a length of stay | |
| 650 | 4 | |a patient education handout | |
| 650 | 4 | |a postoperative complications | |
| 700 | 1 | |a Testa, Gabriele |e verfasserin |4 aut | |
| 700 | 1 | |a Tomasoni, Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Mattavelli, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Del Bon, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Montalto, Nausica |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrari, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Andreoli, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Morello, Riccardo |e verfasserin |4 aut | |
| 700 | 1 | |a Sbalzer, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Vecchiati, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Piazza, Cesare |e verfasserin |4 aut | |
| 700 | 1 | |a Nicolai, Piero |e verfasserin |4 aut | |
| 700 | 1 | |a Deganello, Alberto |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale |d 1985 |g 42(2022), 4 vom: 01. Aug., Seite 325-333 |w (DE-627)NLM01279046X |x 1827-675X |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2022 |g number:4 |g day:01 |g month:08 |g pages:325-333 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.14639/0392-100X-N2072 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2022 |e 4 |b 01 |c 08 |h 325-333 | ||